Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × ER+ Breast Cancer × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 121 Carcinoma, Intraductal, Noninfiltrating 7 Neoplasm Metastasis 6 Breast Neoplasms, Male 4 Breast Carcinoma In Situ 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Breast Diseases 3 Arthralgia 3 Advanced Breast Cancer 3 Neoplasms 2 Breast Cancer Metastatic 2 Solid Tumor 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Obesity 1 Muscle Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Locoregional Recurrence 1 Invasive Breast Cancer 1 Hypogonadism 1 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 HER2-positive Breast Cancer 1

Interventions

Tamoxifen 2 palbociclib 1 exemestane 1 elacestrant 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04985266 2024-12-05

TRAK-ER

Royal Marsden NHS Foundation Trust

Phase 2 Recruiting

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡